Floatz logo

22 assets in Papillary Renal Cell Carcinoma

Therapeutic assets addressing Papillary Renal Cell Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Irinotecan
Papillary Renal Cell Carcinoma
National Cancer Institute (NCI)P2BB (68)
Cyclophosphamide
Papillary Renal Cell Carcinoma
First Affiliated Hospital, Sun Yat-Sen UniversityP3BB (67)
Pembrolizumab
Papillary Renal Cell Carcinoma
First Affiliated Hospital, Sun Yat-Sen UniversityP3BB (67)
Cabozantinib
Papillary Renal Cell Carcinoma
National Cancer Institute (NCI)P2BB (66)
Volitinib
Papillary Renal Cell Carcinoma
AstraZenecaP3BB (66)
Durvalumab
Papillary Renal Cell Carcinoma
AstraZenecaP3B (63)
Nivolumab
Papillary Renal Cell Carcinoma
City of Hope Medical CenterP2B (60)
Axitinib
Papillary Renal Cell Carcinoma
Centre Leon BerardP2B (57)
Atezolizumab
Papillary Renal Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Dentalfluoro
Papillary Renal Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Ipilimumab
Papillary Renal Cell Carcinoma
Bradley A. McGregor, MDP2CCC (53)
Pamiparib
Papillary Renal Cell Carcinoma
Jonsson Comprehensive Cancer CenterP2CCC (53)
Palbociclib
Papillary Renal Cell Carcinoma
National Cancer Institute (NCI)P1/2CCC (48)
jk08
Papillary Renal Cell Carcinoma
Salubris Biotherapeutics IncP1/2CC (47)
Lenvatinib
Papillary Renal Cell Carcinoma
Salubris Biotherapeutics IncP1/2CC (47)
Clostridium Butyricum Miyairi 588
Papillary Renal Cell Carcinoma
City of Hope Medical CenterP1CC (43)
Sasanlimab
Papillary Renal Cell Carcinoma
National Cancer Institute (NCI)P1/2D (31)
13C-Fructose
Papillary Renal Cell Carcinoma
University of Texas Southwestern Medical CenterN/AD (30)
Acetic-1-13C Acid
Papillary Renal Cell Carcinoma
University of Texas Southwestern Medical CenterN/AD (30)
Glucose, Anhydrous
Papillary Renal Cell Carcinoma
University of Texas Southwestern Medical CenterN/AD (30)
Glutamine
Papillary Renal Cell Carcinoma
University of Texas Southwestern Medical CenterN/AD (30)
Lactate
Papillary Renal Cell Carcinoma
University of Texas Southwestern Medical CenterN/AD (30)